Grants and Contributions:

Back to search

Title:

Lab support

Agreement Number:

1008536

Agreement Value:

$30,000.00

Agreement Date:

Aug 1, 2023 - Mar 31, 2024

Description:

Ripple Therapeutics Corporation is a clinical stage, privately held company that is focused on ophthalmic therapeutics with controllable, sustainable drug delivery. A new technical resource will perform work and analytical screening on the development of Ripple’s local, sustained drug delivery technology for targeted applications and on the maintenance of Ripple's wet chemistry laboratory in Toronto. The position will have a role in analytical testing, lab maintenance, developing test methods and documenting technical processes to support new discovery within Ripple’s drug delivery platform technology.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP’s Youth Employment Program is to assist in increasing the supply of highly qualified people, promoting the benefits of advanced studies, demonstrating federal leadership by investing in the skills required to meet the needs of the knowledge economy and facilitating the transition of highly skilled young people to a rapidly changing labour market.

Location:

Toronto, Ontario, CA M5G 1L7

Reference Number:

172-2023-2024-Q2-1008536

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

760459073

Recipient Type:

For-profit organization

Recipient's Operating Name:

Ripple Therapeutics

Recipient's Legal Name:

Ripple Therapeutics Corp.

Federal Riding Name:

University--Rosedale

Federal Riding Number:

35110

Program:

Industrial Research Assistance Program – Youth Employment Program

Program Purpose:

Coverage:

IRAP Youth Employment Program projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

32541